Health & Society Research Cluster Seminar | Wealth vs Health: How Singapore invested in Biomedical R&D

Singapore has made significant investments in the life sciences from the early 2000s, with the goal of building a new pillar for its manufacturing economy. Within two decades, the country achieved recognition as a leading biomedical hub—this contributes as much as 4% of GDP and has created more than 30,000 high value jobs. Singapore has also achieved an enviable healthcare system, with leading hospitals and medical schools. 

This presentation will trace this journey and examine key outcomes from these investments, as well as how R&D can contribute to more sustainable healthcare in the face of an ageing population and rising costs.

About the Speaker

Prof Benjamin Seet: Deputy Group CEO, National Healthcare Group (Education & Research); Assistant CEO of Tan Tock Seng Hospital (Corporate Services); Adjunct Professor, Lee Kong Chian School of Medicine

Prof Benjamin Seet was formerly Executive Director of the Biomedical Research Council at A*Star, where he oversaw research and innovation spanning the pharmaceutical, biotech, health tech, food and consumer industries. Prior to joining A*Star, he served a 22-year military career, where he held the appointment of Chief of SAF Medical Corps. He further served as Chief Medical Officer of the UN Department of Peacekeeping Operations in New York. 

He serves on various boards and advisory committees. He currently sees himself as an evangelist for COVID-19 vaccination.